Abstract
Nanoparticles (NPs) are spherically-shaped solids with an average 100nm size, synthesized from naturally or synthetically occurring polymers. Nowadays, nanotechnology is being widely used in biomedical science for treating a number of diseases like cancer. Poly(lactic-co-glycolic acid) (PLGA) is a successful biodegradable polymer due to its hydrolytic property, and has been approved by the FDA and EMA. PLGA NPs are incorporated in cells via fluid phase pinocytosis as well as via clathrin-mediated endocytosis. Over the past 2 decades, regenerative medicine has been studied widely due to its ability to repair or replace cells and tissues that have been impacted by age, illness, or injuries, and also to normalize congenital abnormalities. This chapter discusses the use of PLGA-based nanoparticles in regenerative medicine.
Original language | English |
---|---|
Title of host publication | Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for Drug Delivery |
Publisher | Elsevier |
Pages | 335-356 |
Number of pages | 22 |
ISBN (Electronic) | 9780323912150 |
ISBN (Print) | 9780323914314 |
DOIs | |
State | Published - 1 Jan 2023 |
Externally published | Yes |
Keywords
- CeO
- Chrysin
- Drug delivery
- Nanomedicine
- Nanoparticles
- PLGA
- PLGA-PEG
- Polymer
- Regenerative medicines
ASJC Scopus subject areas
- General Engineering
- General Materials Science